Article Details

Q&A: Reframing JAK Inhibitor Safety and Flexibility in AD With Leon Kircik, MD

Retrieved on: 2025-06-07 17:50:18

Tags for this article:

Click the tags to see associated articles and topics

Q&A: Reframing JAK Inhibitor Safety and Flexibility in AD With Leon Kircik, MD. View article details on hiswai:

Excerpt

... care provider seems to deem it appropriate. ... In her session, Mayo stressed the need for a patient-centered approach that considers disease burden ...

Article found on: dermatologytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo